The Top 50 Healthcare Technology CEOs of 2021
Scott Durbin, Viveve’s CEO listed in elite group of highly accomplished innovative leaders in healthcare technology industry.
The Healthcare Technology Report, April 14, 2021 (https://thehealthcaretechnologyreport.com/the-top-50-healthcare-technology-ceos-of-2021/)
The Top 25 Women Leaders in Medical Devices of 2021
Viveve’s Senior Vice President of Regulatory and Quality Affairs, Suzon Lommel, recognized for professional expertise and outstanding contributions in medical device industry.
The Healthcare Technology Report, January 26, 2021 (https://thehealthcaretechnologyreport.com/the-top-25-women-leaders-in-medical-devices-of-2021/)
A 12-month Feasibility Study to Investigate the Effectiveness of Cryogen-cooled Monopolar Radiofrequency Treatment for Female Stress Urinary Incontinence
Bruce B. Allan, PhD, MD, FRCS(C), Stacie Bell, PhD, Kathryn Husarek, PhD
Original Research Publication: Canadian Urological Association Journal, July, 2020 (Can Urol Assoc J 2020;14(7):E313-8.) Published online February 4, 2020.
Early Feasibility Study to Evaluate the Viveve System for Female Stress Urinary Incontinence: Interim 6-Month Report
Bruce B. Allan, PhD, MD, FRCS(C), Stacie Bell, PhD, Kathryn Husarek, PhD
Publication: Journal of Women’s Health 2020; Vol 29, No 3:383-389
Viveve and Its New CEO are Pioneering Women’s Intimate Health
Published interview with Scott Durbin, Viveve’s CEO and Director
CEOCFO Magazine, September 16, 2019 (ceocfointerviews.com)
Feasibility Study of Non-Ablative Cryogen-Cooled Monopolar Radiofrequency Treatment for Stress Urinary Incontinence (SUI): Interim 12-Month Results
Bruce B. Allan, PhD, MD, FRCS(C), Stacie Bell, PhD, Kathryn Husarek, PhD
Poster Presentation: Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) February 26 – March 2, 2019 Miami, FL
Safety and Mechanism of Action of Energy-Based Devices for the Treatment of Urogynecologic Conditions
Maria Canter, MD, FPMRS, FACOG, MSc, Steven Lathers, PhD, Stacie Bell, PhD
Poster Presentation: Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) February 26 – March 2, 2019 Miami, FL
Feasibility Study of Non-Ablative Cryogen-Cooled Monopolar Radiofrequency Treatment for Stress Urinary Incontinence (SUI)
Bruce B. Allan, PhD, MD, FRCS(C), Stacie Bell, PhD
Poster Presentation: The 43rd Annual Meeting of International Urogynecological Association (IUGA) June 27-30, 2018 Vienna, Austria
Effect of Single-Session, Cryogen-Cooled Monopolar Radiofrequency Therapy on Sexual Function in Women with Vaginal Laxity: The VIVEVE I Trial (SFSI domains subanalysis)
Michael L. Krychman, MD, Christopher G. Rowan, PhD, Bruce B. Allan, MD, PhD, FRCS(C), Scott Durbin, MPH, Ashley Yacoubian, BSc, and Deborah Wilkerson, PhD
Publication: Journal of Women’s Health 2018; 27:297-304
Effect of Single-Treatment, Surface-Cooled Radiofrequency Therapy on Vaginal Laxity and Female Sexual Function: The VIVEVE I Randomized Controlled Trial
Michael L. Krychman, MD, Christopher G. Rowan, PhD, Bruce B. Allan, MD, PhD, FRCS(C), Leonard DeRogatis, PhD, Scott Durbin, MPH, Ashley Yacoubian, BSc, and Deborah Wilkerson, PhD
Publication: Journal of Sexual Medicine 2017; 14:215-225
